James E. Audia

James E. Audia

Directeur/Membre du Conseil chez
Ribon Therapeutics, Inc.
70 ans
Health Technology
Consumer Services
Commercial Services

Profil

James E.
Audia
is currently the Director at Ribon Therapeutics, Inc. and a Member at Alzheimer's Association.
Previously, he served as the Independent Director at Constellation Pharmaceuticals, Inc. from 2011 to 2021.
He was also the Executive Director at Chicago Biomedical Consortium from 2017 to 2019.
Additionally, he held the position of Head-Chemistry at Karuna Therapeutics, Inc. from 2019 to 2024.
Dr. Audia obtained his doctorate degree from Yale University and the University of South Carolina.

Postes actifs de James E. Audia

SociétésPosteDébut
Directeur/Membre du Conseil 01/04/2018
Corporate Officer/Principal 01/01/2020

Anciens postes connus de James E. Audia

SociétésPosteFin
KARA THER Corporate Officer/Principal 18/03/2024
CONSTELLATION PHARMACEUTICALS, INC. Directeur Technique/Scientifique/R&D 01/07/2017
Chicago Biomedical Consortium
Directeur/Membre du Conseil 01/10/2019
Voir l'expérience en détail de James E. Audia

Formation de James E. Audia

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

55

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Chicago Biomedical Consortium

  1. Bourse
  2. Insiders
  3. James E. Audia
🔇